Patients with metastatic stomach or esophageal cancers driven by a mutated HER2 gene had markedly improved response rates and survival when Avastin (bevacizumab) was added to a combination of capecitabine and oxaliplatin chemotherapy and Herceptin (trastuzumab).
The Biden administration has left NIH in a weakened state, intensifying politicization of science on Capitol Hill and eroding the bipartisan support the government’s premier biomedical research agency has traditionally enjoyed.
